NCT06723119 Effect of Resveratrol Supplementation on Exercise Performance and Recovery
| NCT ID | NCT06723119 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Central Florida |
| Condition | Effect of Resveratrol on Performance and Recovery |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2024-10-01 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To examine the effects of once daily supplementation with 500mg VeriSperse® resveratrol (VRES) for 17 days on muscle function, delayed onset muscle soreness, systemic concentrations of muscular damage markers and markers of oxidative stress in resistance trained young adult males following a damaging isoinertial squat protocol (ISP).
Eligibility Criteria
Inclusion Criteria: * • Male between the ages of 18-40 years old * Healthy, and ready for physical activity as determined by the PAR-Q+, and MHQ. * Participants will be required to be recreationally active (defined according to ACSM standards of at least 150 minutes exercise per week). * Participants will be required to have been actively resistance training for a minimum of 6 months as defined by 3 resistance training sessions per week with at least one lower body session. * Participants must be willing to abstain from the consumption of bananas of non-steroidal anti-inflammatory drugs (NSAIDs) for the duration of their enrollment in study. * Participants must be willing to abstain from dietary supplementation that are viewed by study investigators to confound the outcomes of the study (e.g., Creatine). Those currently supplementing must be willing to undergo a 28-day washout prior to beginning study procedures. * Participants must be consuming \<300 mg·day-1 (Equivalent to 3 cups of coffee per day or 2 16oz cans of Redbull) and willing to keep their caffeine consumption consistent throughout the duration of the study. * Participants will be required to have access to the online MyFitnessPal application either via cellphone or computer and be willing to download and maintain the application for the duration of the study. * Free from previous or current lower body injuries that are viewed by the investigators to potentially limit ability of the participant to perform the assessments. * Willing to abstain from lower body resistance training for the 14 days preceding ET1 and ET2 Exclusion Criteria: * • Individual does not provide consent to participate in this study. * Inability to perform physical exercise (determined by MHQ, and PAR Q+). That is Answering "Yes" to any question on the PAR-Q +, or having a pre-existing condition such as musculoskeletal injury, back pain, chronic pain etc. that the investigative team perceives will prevent a participant from safely completing the protocol. * Not currently participating in at least 150 minutes of physical activity per week. * Not currently resistance trained (as defined within the inclusion criteria) * Currently taking any performance-enhancing drug (determined from health and activity questionnaire) * Currently taking a nutritional supplement known to improve physical performance and not willing refrain form the consumption of the supplement for at least 28-days prior to beginning study procedures. * Regularly taking any type of prescription or over-the-counter medication deemed to affect performance, or having any chronic illnesses, which require medical care. * Have used nicotine or tobacco at any time within the last three months. * Report consuming bananas or NSAIDS at any time during your enrollment in the study. * Report daily caffeine consumption \>300 mg·day-1 * Report any lower extremity muscle soreness for visits ET1 and ET2 * Previous or current lower body injuries viewed by the investigators to potentially limit the ability of the participant to perform the assessments. * Inability or unwillingness to consume the provided standardized snacks and meals in their entirety. * Inability or unwillingness to adhere to the diet restrictions of the study. * Have a food allergy to either of the two provided energy bars. * Inability or unwillingness to report all food and beverage consumption during the two 5-day dietary log periods.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06723119 clinical trial?
This trial is open to male participants only, aged 18 Years or older, up to 40 Years, studying Effect of Resveratrol on Performance and Recovery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06723119 currently recruiting?
Yes, NCT06723119 is actively recruiting participants. Contact the research team at trevor.dufner@ucf.edu for enrollment information.
Where is the NCT06723119 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT06723119 clinical trial?
NCT06723119 is sponsored by University of Central Florida. The trial plans to enroll 20 participants.